Peritumoral Activated Hepatic Stellate Cells Predict Poor Clinical Outcome in Hepatocellular Carcinoma After Curative Resection

被引:121
作者
Ju, Min-Jie
Qiu, Shuang-Jian
Fan, Jia
Xiao, Yong-Sheng
Gao, Qiang
Zhou, Jian
Li, Yi-Wei
Tang, Zhao-You
机构
[1] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Sch, Shanghai 200032, Peoples R China
[3] Chinese Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China
关键词
Hepatocellular carcinoma; Peritumoral microenvironment; Hepatic stellate cells; Inflammation; Prognosis; EXPERIMENTAL MELANOMA METASTASIS; TUMOR-ASSOCIATED MACROPHAGES; INTRAHEPATIC RECURRENCE; STAGING SYSTEMS; EXPRESSION; PROGNOSIS; LIVER; SURVIVAL; CANCER; PROTEIN;
D O I
10.1309/AJCP86PPBNGOHNNL
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The inflammatory components of the liver remnant after hepatocellular carcinoma (HCC) resection are of prognostic importance. We evaluated prognostic potential of peritumoral activated hepatic stellate cells (HSCs) in 130 HCC cases. The messenger RNA (mRNA) levels of the functional genes in HSCs (ie, seprase, osteonectin, and tenascin-C), quantitated by real-time quantitative polymerase chain reaction, and the density of peritumoral Foxp3+ T-regulatory cells (Tregs) and CD68+ macrophages (M Phi), assessed immunohistochemically in tissue microarray sections, were positively correlated with the density of peritumoral activated HSCs. The density (P 007,for recurrence-free survival [RFS] and P =.021 for overall survival [OS]) and functional genes (seprase, P =. 001 for RFS; osteonectin, P = .007 for RFS and P =. 021 for OS) of Peritumoral activated HSCs independently contributed to high recurrence or death rates, as did peritumoral Tregs or M Phi. Moreover, peritumoral HSCs were related to more early recurrences. It is important to note that the density of peritumoral activated HSCs, in combination with seprase and osteonectin mRNA or density, of Tregs and M Phi, might predict prognoses more effectively.
引用
收藏
页码:498 / 510
页数:13
相关论文
共 42 条
[1]   Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment [J].
Budhu, Anuradha ;
Forgues, Marshonna ;
Ye, Qing-Hai ;
Jia, Hu-Liong ;
He, Ping ;
Zanetti, Krista A. ;
Kammula, Udai S. ;
Chen, Yidong ;
Qin, Lun-Xiu ;
Tang, Zhao-You ;
Wang, Xin Wei .
CANCER CELL, 2006, 10 (02) :99-111
[2]   Dendritic cell infiltration and prognosis of human hepatocellular carcinoma [J].
Cai, XY ;
Gao, Q ;
Qiu, SJ ;
Ye, SL ;
Wu, ZQ ;
Fan, J ;
Tang, ZY .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (05) :293-301
[3]   Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers [J].
Cassiman, D ;
Libbrecht, L ;
Desmet, V ;
Denef, C ;
Roskams, T .
JOURNAL OF HEPATOLOGY, 2002, 36 (02) :200-209
[4]   In vivo immune modulatory activity of hepatic stellate cells in mice [J].
Chen, Cheng-Hsu ;
Kuo, Liang-Mou ;
Chang, Yigang ;
Wu, Wenhan ;
Goldbach, Christina ;
Ross, Mark A. ;
Stolz, Donna B. ;
Chen, Liepin ;
Fung, John J. ;
Lu, Lin ;
Qian, Shiguang .
HEPATOLOGY, 2006, 44 (05) :1171-1181
[5]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
[6]  
2-E
[7]   Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C [J].
El-Karef, Amro ;
Kaito, Masahiko ;
Tanaka, Hideaki ;
Ikeda, Kazuo ;
Nishioka, Tomohiro ;
Fujita, Naoki ;
Inada, Hiroyasu ;
Adachi, Yukihiko ;
Kawada, Norifumi ;
Nakajima, Yuji ;
Imanaka-Yoshida, Kyoko ;
Yoshida, Toshimichi .
JOURNAL OF HEPATOLOGY, 2007, 46 (04) :664-673
[8]  
ENZAN H, 1994, HEPATOLOGY, V19, P895, DOI 10.1002/hep.1840190415
[9]  
Faouzi S, 1999, LAB INVEST, V79, P485
[10]   Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver [J].
Friedman, Scott L. .
PHYSIOLOGICAL REVIEWS, 2008, 88 (01) :125-172